A detailed history of Gamma Investing LLC transactions in Nevro Corp stock. As of the latest transaction made, Gamma Investing LLC holds 41 shares of NVRO stock, worth $162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41
Holding current value
$162
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$4.71 - $10.1 $193 - $414
41 New
41 $229,000
Q1 2024

Apr 05, 2024

BUY
$13.56 - $20.78 $840 - $1,288
62 New
62 $895,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.